PDRX Financial Statements From 2010 to 2026
| PDRX Stock | USD 2.90 0.00 0.00% |
Check Pd Rx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pd Rx's main balance sheet or income statement drivers, such as , as well as many indicators such as . PDRX financial statements analysis is a perfect complement when working with Pd Rx Valuation or Volatility modules.
PDRX |
Pd Rx Pharmaceutical Company Return On Equity Analysis
Pd Rx's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pd Rx Return On Equity | 0.25 |
Most of Pd Rx's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pd Rx Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pd Rx Pharmaceutical has a Return On Equity of 0.2457. This is 101.03% lower than that of the Health Care Providers & Services sector and 96.7% lower than that of the Health Care industry. The return on equity for all United States stocks is 179.26% lower than that of the firm.
Pd Rx Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pd Rx's current stock value. Our valuation model uses many indicators to compare Pd Rx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pd Rx competition to find correlations between indicators driving Pd Rx's intrinsic value. More Info.Pd Rx Pharmaceutical is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pd Rx Pharmaceutical is roughly 4.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pd Rx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pd Rx's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Pd Rx Financial Statements
Pd Rx investors use historical fundamental indicators, such as Pd Rx's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pd Rx. Please read more on our technical analysis and fundamental analysis pages.
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. PD-Rx Pharmaceuticals, Inc. was incorporated in 1986 and is headquartered in Oklahoma City, Oklahoma. Pd-Rx Pharmaceutical operates under Medical Distribution classification in the United States and is traded on OTC Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PDRX Pink Sheet Analysis
When running Pd Rx's price analysis, check to measure Pd Rx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd Rx is operating at the current time. Most of Pd Rx's value examination focuses on studying past and present price action to predict the probability of Pd Rx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd Rx's price. Additionally, you may evaluate how the addition of Pd Rx to your portfolios can decrease your overall portfolio volatility.